Key result
Hexarelin inhibited ANG II-induced proliferation, DNA and collagen synthesis, and TGF-beta expression in cultured rat cardiac fibroblasts via GHSR and A2R activation.
Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in vitro, suggesting a potential mechanism for its protective effects against cardiac remodeling.
Hexarelin may attenuate fibroblast-driven fibrosis in vitro; animal data leave open in vivo remodeling effects and clinical translation.
Abnormal growth of cardiac fibroblasts is critically involved in the pathophysiology of cardiac hypertrophy/remodeling. Hexarelin is a synthetic growth hormone secretagogue (GHS), which possesses a variety of cardiovascular protective activities mediated via the GHS receptor (GHSR), including improving cardiac dysfunction and remodeling. The cellular and molecular mechanisms underlying the effect of GHS on cardiac fibrosis are, however, not clear. In this report, cultured cardiac fibroblasts from 8-day-old rats were stimulated with ANG II or FCS to induce proliferation. The fibroblast proliferation and DNA and collagen synthesis were evaluated utilizing 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, (3)H-thymidine incorporation, and (3)H-proline incorporation. The level of mRNA of transforming growth factor (TGF)-beta was evaluated by RT-PCR, and the active TGF-beta1 release from cardiac fibroblasts was evaluated by ELISA. The level of cellular cAMP was measured by radioimmunoassay. In addition, the effects of 3,7-dimethyl-l-propargylxanthine (DMPX; a specific adenosine receptor A(2)R antagonist) and 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; a specific A(1)R antagonist) were tested. It was found that incubation with 10(-7) mol/l hexarelin for 24 h 1) inhibited the ANG II-induced proliferation and collagen synthesis and the 5% FCS- and TGF-beta-induced increase of DNA synthesis in cardiac fibroblast and 2) reduced ANG II-induced upregulation of TGF-beta mRNA expression and active TGF-beta1 release from fibroblasts. Hexarelin increased the cellular level of cAMP in cardiac fibroblasts. DMPX (10(-8) mol/l) but not DPCPX abolished the effect of hexarelin on cardiac fibroblast DNA synthesis. It is concluded that hexarelin inhibits DNA and collagen synthesis and proliferation of cardiac fibroblasts through activation of both GHSR and A(2)R and diminishment of ANG II-induced increase in TGF-beta expression and release.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2007) studied Cardiac fibrosis. Hexarelin vs. ANG II or FCS alone was evaluated on Fibroblast proliferation, DNA and collagen synthesis, and TGF-beta expression. Hexarelin inhibited ANG II-induced proliferation, DNA and collagen synthesis, and TGF-beta expression in cultured rat cardiac fibroblasts via GHSR and A2R activation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: